Federal Register / Vol. 72, No.
62 / Monday, April 2, 2007 / Notices 15707
Dated: March 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1611 Filed 3–20–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; High-Accuracy Protein Structure
Meeting.
Date: April 20, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: C Craig Hyde, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
MSC 6200, Bethesda, MD 20892, (301) 435–
3825, hydec@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
hsrobinson on PROD1PC76 with NOTICES
Dated: March 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1613 Filed 3–30–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005 18:39 Mar 30, 2007 Jkt 211001
DEPARTMENT OF HEATLH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal concerning individuals
associated with the contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Innovative
Therapies and Clinical Studies For
Screenable Disorders.
Date: April 27, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington National
Airport, 1489 Jefferson Davis Hwy.,
Arlington, VA 22202.
Contact Person: Norman Chang, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, (301) 496–1486,
changn@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1614 Filed 3–30–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\02APN1.SGM
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Melanoma
Application.
Date: April 9, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mary Bell, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 6188, MSC 7804,
Bethesda, MD 20892, 301–451–8754,
bellmar@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neuropharmacology and Drug Discovery.
Date: April 10, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Boris P. Sokolov, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–435–
1197, bsokolov@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—B Study Section.
Date: May 31–June 1, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Hayden, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
02APN1
 15708 Federal Register / Vol. 72, No. 62 / Monday, April 2, 2007 / Notices
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1615 Filed 3–30–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Statement of Organization, Functions,
and Delegations of Authority
Part M of the Substance Abuse and
Mental Health Services Administration
(SAMHSA) Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services at 71, Number 137, FR
40730–40731, July 18, 2006 is amended
to reflect the new functional statements
for the Center for Substance Abuse
Treatment (CSAT), Division of Services
Improvement (DSI), and the Division of
State and Community Assistance
(DSCA). The restructuring of DSI will
ensure that all activities are
consolidated within a structure
reflective of current Agency priorities,
such as health service systems
development, program quality
improvement, and targeted priority
populations. The DSCA role and
responsibility will be clarified and made
much more relevant to today’s
performance management environment.
This realignment of functions will have
a positive impact on organizational
effectiveness. The changes are as
follows:
Section M.20, Functions is amended
as follows:
The functional statements for the
Center for Substance Abuse Treatment
(MT), Division of Services Improvement
(MTB), and the Division of State and
Community Assistance (MTE) are
replaced with the following:
Center for Substance Abuse Treatment
(MT)
Division of Services Improvement (MTB)
(1) Develops, plans, implements, and
monitors a national treatment capacity
expansion and knowledge adoption
program designed to improve treatment
services for targeted populations served
hsrobinson on PROD1PC76 with NOTICES
by both the specialty drug treatment
system and other systems of care; (2)
provides leadership and guidance to
CSAT on strategies to improve the
quality of drug treatment services
delivered nationwide; (3) supports the
VerDate Aug<31>2005 18:39 Mar 30, 2007 Jkt 211001
development and testing of substance
abuse performance measures for public
and private health plans; (4) collects,
analyzes, and disseminates data and
information pertaining to public and
private financing and expenditures for
treatment services; (5) assesses and
responds to the identified needs for
workforce development among
substance abuse treatment and recovery
support providers; (6) collaborates on
the development of requests for
applications and requests for contracts
for the national treatment capacity
expansion, knowledge adoption, quality
and services improvement agenda; (7)
monitors grants, cooperative
agreements, contracts, interagency
agreements, and memoranda of
understanding for treatment capacity
expansion, knowledge adoption, and
quality and services improvement; (8)
identifies the need for, develops, and
provides technical assistance to
grantees, other service providers and
systems of care, and others on adoption
of evidence-based practices to promote
quality and services improvement,
capacity expansion, and organization
and financing of services; (9) establishes
and maintains collaborative
relationships with other Federal, State,
and local governmental agencies,
national organizations, and constituency
groups; (10) maintains internal expertise
and collaborates with national experts
on the science-to-services agenda; and
(11) develops funding levels for
Division programs and activities.
Division of State and Community
Systems Development (MTE)
(1) Administers the Substance Abuse
Block Grant Program, including
oversight and approval of Block Grant
applications and maintenance of effort
(MOE) issues; (2) administers the
Substance Abuse Treatment National
Outcome Measures (NOMs), negotiating
quality improvement agreements with
States; (3) monitors and ensures State
compliance with legislative and
regulatory provisions which apply to
SAPTBG funds at State and provider
levels; (4) provides guidance and
technical assistance to States in
preparation of State substance abuse
plans; (5) conducts performance reviews
of State agencies and treatment
programs; (6) works closely with data
and evaluation to assure proper
reporting and data integrity; (7)
administers the State Incentive Grant
program for co-occurring disorders and
the Targeted Capacity Expansion (TCE)
grant program for co-occurring disorders
and homelessness; (8) works
collaboratively with the Division of
Services Improvement on performance
PO 00000 Frm 00065 Fmt 4703 Sfmt 4703
measurement, GPRA, and HIPAA issues;
and (9) serves as focus for State and
local performance data analysis and
development issues.
Delegations of Authority
All delegations and redelegations of
authority to officers and employees of
SAMHSA which were in effect
immediately prior to the effective date
of this reorganization shall continue to
be in effect pending further
redelegations, providing they are
consistent with the reorganization.
These organizational changes are effective:
Dated: March 22, 2007.
Terry L. Cline,
Administrator.
[FR Doc. E7–6014 Filed 3–30–07; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the following information
collection to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
includes the actual data collection
instruments FEMA will use.
Title: National Fire Academy End of
Course Evaluation Form.
OMB Number: 1660–0032.
Abstract: The National Fire Academy
(NFA) is mandated under the Fire
Prevention and Control Act of 1974
(Pub. L. 93–498) to provide training and
education to the Nation’s fire service
and emergency service personnel. The
NFA End of Course Evaluation Form is
used to evaluate all traditional
classroom based course deliveries. The
data provided by students evaluating
NFA courses are used to determine the
need for course improvements and the
degree of student satisfaction with the
training experience. All on-campus
E:\FR\FM\02APN1.SGM 02APN1